Hereditary non-polyposis colorectal cancer (HNPCC) is a common autosomal dominant condition characterized by early onset colorectal cancer as well as other tumour types at different anatomical sites1. HNPCC tumours often display a high level of genomic instability, characterized by changes in repeat numbers of simple repetitive sequences (microsatellite instability, MSI), which reflects the malfunction of the DNA mismatch repair machinery2,3. Accordingly, HNPCC was shown to be caused by germline mutations in the DNA mismatch repair genes (MMR) MSH2, MLH1, PMS1, PMS2 and MSH6 (refs 3, 4, 5, 6). So far, more than 220 predisposing mutations have been identified, most in MSH2 and MLH1 and in families complying with the clinical Amsterdam criteria3,7,8 (AMS+). Many HNPCC families, however, do not fully comply with these criteria, and in most cases the causative mutations are unknown.
Previously, we determined the prevalence of pathogenic mutations at MSH2 and MLH1 among 287 kindreds, of which 133 were AMS+ and 154 showed familial clustering of cancers reminiscent of HNPCC. Approximately one-half of AMS+ families revealed a predisposing mutation, whereas only 7% of AMS– families had a mutation in either gene8,9,10. Here we analyse MSH6 by denaturing gradient gel electrophoresis (DGGE) in the remaining 214 kindreds, 71 AMS+ and 143 AMS–, in which no MSH2 or MLH1 mutations were found. We identified 9 different MSH6 pathogenic germline mutations in 10 kindreds (Table 1). These mutations were scattered along the coding sequence of MSH6 and predict the truncation of its protein product. We found 7 of 10 MSH6 mutations in atypical HNPCC families not fulfilling the Amsterdam criteria (7/154, 4.5%). These kindreds display a very high frequency of atypical hyperplastic lesions and carcinomas of the endometrium: 73% in female MSH6 mutation carriers compared with 29% in MSH2 and 31% in MLH1. Moreover, delayed age of cancer onset and incomplete penetrance were characteristic clinical features of the MSH6 mutation carriers (see Table 3 and Fig. 1, http://genetics.nature.com/supplementary_info/).
This is a preview of subscription content, access via your institution
Access options
Change institution
Buy or subscribe
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Learn more
Prices may be subject to local taxes which are calculated during checkout
References
Lynch, H.T. et al. Gastroenterology 104, 1535–1549 (1993).
Ionov, Y. et al. Nature 363, 558–561 (1993).
Peltomäki, P. et al. Gastroenterology 113, 1146–1158 (1997).
Akiyama, Y. et al. Cancer Res. 57, 3920–3923 (1997).
CAS Google Scholar
Miyaki, M. et al. Nature Genet. 17, 271–272 (1997).
Wu, Y. et al. Am. J. Hum. Genet. (in press).
Vasen, H.F.A. et al. Dis. Colon Rectum 34, 424–425 (1991).
Wijnen, J.T. et al. Am. J. Hum. Genet. 61, 329–335 (1997).
Wijnen, J.T. et al. N. Engl. J. Med. 339, 511–518 (1998).
Wijnen, J.T. et al. Nature Genet. 20, 326–328 (1998).
Boland, C.R. et al. Cancer Res. 58, 5248–5257 (1998).
CAS PubMed Google Scholar
Drummond, J.T. et al. Science 268, 1909–1912 (1995).
Genschel, J. et al. J. Biol. Chem. 273, 19895–19901 (1998).
Lu, S. et al. Biochem. Biophys. Res. Commun. 216, 452–457 (1995).
Vasen, H.F.A. et al. Gasteroenterology 116, 1453–1456 (1999).
Acknowledgements
We thank G.-J. van Ommen and N. de Wind for discussions; I. van Leeuwen-Cornelisse for collecting blood samples; and clinicians J. Apold, H. Brunner, G. Griffioen, J. Kleibeuker, F. Nagengast, J. Post, C. Schaap and B. Taal. This study has been supported by grants from the Dutch Cancer Society and Praeventiefonds, and by a grant (118571/320) from the Norges Forskningsraad to P.M.
Author information
Authors and Affiliations
MGC-Department of Human and Clinical Genetics,
Juul Wijnen,Heleen van der Klift&Riccardo Fodde
Department of Pathology, Leiden University Medical Center (LUMC), Leiden, The Netherlands
Wiljo de Leeuw,Cees Cornelisse&Hans Morreau
Foundation for the Detection of Hereditary Tumors and Department of Gastroenterology, LUMC, Leiden, The Netherlands
Hans Vasen
Unit of Medical Genetics, The Norwegian Radium Hospital, Oslo, Norway
Pål Møller&Astrid Stormorken
MGC-Department of Clinical Genetics, Erasmus University, Rotterdam, The Netherlands
Hanne Meijers-Heijboer&Dick Lindhout
Department of Clinical Genetics, Free University Hospital, Amsterdam, The Netherlands
Fred Menko
Department of Surgery, Heinrich Heine University, Düsseldorf, Germany
Sandra Vossen&Gabriela Möslein
Clinical Genetics Center Leiden, LUMC, Leiden, The Netherlands
Carli Tops&Annette Bröcker-Vriends
Department of Medical Genetics, University of Groningen, Groningen, The Netherlands
Ying Wu,Robert Hofstra&Rolf Sijmons
Authors
- Juul Wijnen
View author publications
You can also search for this author in PubMedGoogle Scholar
- Wiljo de Leeuw
View author publications
You can also search for this author in PubMedGoogle Scholar
- Hans Vasen
View author publications
You can also search for this author in PubMedGoogle Scholar
- Heleen van der Klift
View author publications
You can also search for this author in PubMedGoogle Scholar
- Pål Møller
View author publications
You can also search for this author in PubMedGoogle Scholar
- Astrid Stormorken
View author publications
You can also search for this author in PubMedGoogle Scholar
- Hanne Meijers-Heijboer
View author publications
You can also search for this author in PubMedGoogle Scholar
- Dick Lindhout
View author publications
You can also search for this author in PubMedGoogle Scholar
- Fred Menko
View author publications
You can also search for this author in PubMedGoogle Scholar
- Sandra Vossen
View author publications
You can also search for this author in PubMedGoogle Scholar
- Gabriela Möslein
View author publications
You can also search for this author in PubMedGoogle Scholar
- Carli Tops
View author publications
You can also search for this author in PubMedGoogle Scholar
- Annette Bröcker-Vriends
View author publications
You can also search for this author in PubMedGoogle Scholar
- Ying Wu
View author publications
You can also search for this author in PubMedGoogle Scholar
- Robert Hofstra
View author publications
You can also search for this author in PubMedGoogle Scholar
- Rolf Sijmons
View author publications
You can also search for this author in PubMedGoogle Scholar
- Cees Cornelisse
View author publications
You can also search for this author in PubMedGoogle Scholar
- Hans Morreau
View author publications
You can also search for this author in PubMedGoogle Scholar
- Riccardo Fodde
View author publications
You can also search for this author in PubMedGoogle Scholar
Corresponding author
Correspondence to Riccardo Fodde.
Supplementary information
Rights and permissions
About this article
Cite this article
Wijnen, J., Leeuw, W., Vasen, H. et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23, 142–144 (1999). https://doi.org/10.1038/13773
Issue Date:
DOI: https://doi.org/10.1038/13773
This article is cited by
-
An MSH6 germline pathogenic variant p.Gly162Ter associated with Lynch syndrome
- Olga A. Vostrukhina
- Elena D. Mirlina
- Valery N. Verbenko
Human Genome Variation (2022)
-
Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review
- Tong Xie
- Qin Feng
- Zhi Peng
Hereditary Cancer in Clinical Practice (2021)
-
DNA repair- and nucleotide metabolism-related genes exhibit differential CHG methylation patterns in natural and synthetic polyploids (Brassica napus L.)
- Liqin Yin
- Zhendong Zhu
- Shaohong Fu
Horticulture Research (2021)
-
The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care
- Pål Møller
Hereditary Cancer in Clinical Practice (2020)